XClose

UCL Design Language

Home

A nascent retina, generated from a 3D embryonic stem cell culture

Menu
Contents
Metadata
Published
Display
per page
Located
km
Within

1 - 10 of 1,132 search results for !padrenullquery -UclAudience:staff -UclAudience:students UclOrgUnit:"UCL News"

Results

  1. Bees grooming each other can boost colony immunity | UCL News - UCL – …

    https://www.ucl.ac.uk/news/2020/jun/bees-grooming-each-other-can-boost-colony-immunity

    2 Jun 2020: Honeybees that specialise in grooming their nestmates (allogroomers) to ward off pests play a central role in the colony, finds a new UCL and University of Florence study.

    Honeybees that specialise in grooming their nestmates (allogroomers) to ward off pests play a central role in the colony, finds a new UCL and University of Florence study.

  2. Gene discovery in fruit flies ‘opens new doors’ for hearing loss cure …

    https://www.ucl.ac.uk/news/2020/jun/gene-discovery-fruit-flies-opens-new-doors-hearing-loss-cure-elderly-0

    2 Jun 2020: Scientists at UCL have discovered sets of regulatory genes, which are responsible for maintaining healthy hearing. The finding, made in fruit flies, could potentially lead to treatments for age-related hearing loss (ARHL) in humans.

    Scientists at UCL have discovered sets of regulatory genes, which are responsible for maintaining healthy hearing. The finding, made in fruit flies, could potentially lead to treatments for age-related hearing loss (ARHL) in humans.

  3. COVID-19: UCL academics mobilise to provide critical advice and…

    https://www.ucl.ac.uk/news/2020/jun/covid-19-ucl-academics-mobilise-provide-critical-advice-and-expert-comment

    1 Jun 2020: As coronavirus spreads around the world, UCL experts are taking a prominent role in advancing public knowledge about the virus by advising world leaders, providing expert comment in the media and urgently researching new ways of tackling COVID-19.

    As coronavirus spreads around the world, UCL experts are taking a prominent role in advancing public knowledge about the virus by advising world leaders, providing expert comment in the media and urgently researching new ways of tackling COVID-19.

  4. People are optimistic about own Covid-19 risk, pessimistic about…

    https://www.ucl.ac.uk/news/2020/may/people-are-optimistic-about-own-covid-19-risk-pessimistic-about-society

    29 May 2020: Most people believe themselves to be less at risk from Covid-19 than others of their own age and gender, indicating an optimism bias, according to a recent UCL survey conducted in the US.

    Most people believe themselves to be less at risk from Covid-19 than others of their own age and gender, indicating an optimism bias, according to a recent UCL survey conducted in the US.

  5. Mapping COVID-19 effects and treatments in patients’ blood | UCL News …

    https://www.ucl.ac.uk/news/2020/may/mapping-covid-19-effects-and-treatments-patients-blood

    28 May 2020: A new coalition of more than 500 scientists from 18 countries, involving UCL, will share data on COVID-19 gleaned from the use of mass spectrometry techniques which examine people’s blood and other biomarkers.

    A new coalition of more than 500 scientists from 18 countries, involving UCL, will share data on COVID-19 gleaned from the use of mass spectrometry techniques which examine people’s blood and other biomarkers.

  6. Immunotherapy for bowel cancer could change clinical practice | UCL…

    https://www.ucl.ac.uk/news/2020/may/immunotherapy-bowel-cancer-could-change-clinical-practice

    28 May 2020: A large international trial involving UCL and UCLH has found that pembrolizumab, a form of immunotherapy, more than doubled the ‘progression free survival’ time of patients with a specific subtype of advanced bowel cancer, when compared with

    A large international trial involving UCL and UCLH has found that pembrolizumab, a form of immunotherapy, more than doubled the ‘progression free survival’ time of patients with a specific subtype of advanced bowel cancer, when compared with chemotherapy.

  7. Two UCL academics among WEF Young Scientists | UCL News - UCL –…

    https://www.ucl.ac.uk/news/2020/may/two-ucl-academics-among-wef-young-scientists

    27 May 2020: Dr Mine Orlu (UCL School of Pharmacy) and Dr Joe Grove (UCL Institute of Immunity & Transplantation) have been named to the World Economic Forum’s Class of 2020 Young Scientists, a global list of exceptional researchers at the forefront of

    Dr Mine Orlu (UCL School of Pharmacy) and Dr Joe Grove (UCL Institute of Immunity & Transplantation) have been named to the World Economic Forum’s Class of 2020 Young Scientists, a global list of exceptional researchers at the forefront of scientific discovery.

  8. Optimal time to treat Huntington’s disease identified | UCL News -…

    https://www.ucl.ac.uk/news/2020/may/optimal-time-treat-huntingtons-disease-identified

    27 May 2020: The earliest brain changes due to Huntington’s disease can be detected 24 years before clinical symptoms show, according to a new UCL-led study.

    The earliest brain changes due to Huntington’s disease can be detected 24 years before clinical symptoms show, according to a new UCL-led study.

  9. Strong convictions can blind us to information that challenges them | …

    https://www.ucl.ac.uk/news/2020/may/strong-convictions-can-blind-us-information-challenges-them

    27 May 2020: When people are highly confident in a decision, they take in information that confirms their decision, but fail to process information which contradicts it, finds a UCL brain imaging study.

    When people are highly confident in a decision, they take in information that confirms their decision, but fail to process information which contradicts it, finds a UCL brain imaging study.

  10. Analysis: Take lessons from cancer evolution to the clinic | UCL News …

    https://www.ucl.ac.uk/news/2020/may/analysis-take-lessons-cancer-evolution-clinic

    27 May 2020: ​​​​​​​TRACERx, the first long-term study of how lung cancer evolves, is revealing that therapies targeting multiple proteins in tumour cells could help outpace the disease. Here, Chief Investigator Professor Charles Swanton (UCL

    ​​​​​​​TRACERx, the first long-term study of how lung cancer evolves, is revealing that therapies targeting multiple proteins in tumour cells could help outpace the disease. Here, Chief Investigator Professor Charles Swanton (UCL Cancer Institute), discusses the latest findings.

Pagination

Refine

Subjects

Organisational Units : all → School of Life & Medical Sciences

Communication types

Audiences